“R1 RCM is positioned as a leader in the underpenetrated outsourced revenue cycle management industry, bolstered by the integration of Cloudmed and margin expansion through AI initiatives. Despite negative short-term sentiment and idiosyncratic headwinds, the stock offers deep value and strong downside protection relative to its cash flow generation.”
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.